Sterling Biotech, a major pharmaceutical company with two manufacturing facilities in Gujarat, specializes in Gelatine, Di-Calcium Phosphate and select APIs. Once the deal concludes, Sterling Biotech will transition into a 50:50 joint venture, ensuring equal representation for both parties on the board.
